coronavirus

Two drugs, chloroquine (CQ), and hydroxychloroquine (HCQ) are all over the news because both drugs are being extensively studied for their antiviral potential against coronavirus.

You just can't hype drugs. They are either going to work well or not. Wishful thinking doesn't help. Neither does bluster. Nonetheless, we're now getting quite a dose of hype and bluster in recent days.

Obvious from the title, today’s blog is going to ramble a bit. I don’t apologize.   

There is now a potentially important change in the pharmaceutical landscape of anti-coronavirus drugs.

This article was originally published at Geopolitical Futures. The original is here.

The coronavirus pandemic we are experiencing today has been contemplated by some of the world’s best scientists for at least the last 30 years.

It says something profoundly troubling about the times in which we live that Americans are using a genuine public health crisis to sow division, stir animosity, and score political points. But that's where we find ourselves in 2020.

Even if an effective vaccine for the Wuhan coronavirus is discovered, which is by no means a certainty, it will be at least a year (more likely two) before you'll be rolling up your sleeve.

Perhaps other than virologists, few people would have predicted that a tiny microbe would dominate global headlines for several months in 2020. It goes without saying that the coronavirus has kept us quite busy.